Page 1

Corporate Report: 2017


About PharMedQuest Mission Statement Delivering the highest cost-effective care to patients by investing in optimal resources to build transformational & innovative tools, knowledge, and management for clinicians & payors.

Vision Statement Our vision is to energize and empower our healthcare communities to improve the lives of the patients we serve.

ÂŽ


2016

came and went, and based on the progress we made at PharMedQuest, we look forward to 2017 with great confidence and enthusiasm. We placed in the top 42% in the INC. Top 5000 fastest growing companies with a 142% growth rate. We are proud to have invested over $3.5 million in our team, technology, innovations and training. PharMedQuest focuses on delivering innovative solutions to our clients and positively impacting the communities we work in. On a daily basis, PharMedQuest strives to deliver a greater level of certainty for our clients in an uncertain healthcare environment. We are committed to providing our clients with high-quality, transparent deliverables. PharMedQuest would like to thank all of our clients, vendors, and most of all, our dedicated team for our journey into 2017. We are grateful, humbled, and eager to continue to earn our keep and to provide our best. Cheers, and please feel free to reach out to me or any of our team members with questions, requests or recommendations.

Chris Nee, PharmD, MBA CEO and President

“It is a great privilege and honor for PharMedQuest to be included on the Inc. 5000 list of the fastest-growing private companies in America for 2016. This recognition is a reflection of the hard work, dedication and innovative thinking that each and every team member at PharMedQuest puts in on a daily basis.�

The PharMedQuest Team


EXPERIENCE

INSIGHT VALUE 


PharMedQuest at a Glance (2016) We Have Invested Over $3.5 Million In Our Team Management Technology Pharmacy Technology



P340B® Reporting ACE - Clinical CRM

2016

re P rof e

ssio

nal s

Dispensing Automation

19

11 MDs

51.7%

Company Growth

are

Lic ens

14

9

73 %

2014

38.7% Pharmacies

2015

34 Pharmacists

ed

He al

thc a

33.6%

Revenue Growth

3-Year Progress

Managing > 1.5 Million Covered Lives

ARCTM 1.0 --> 2.0

48 Other

87 Pharmacy Technicians

Our Team


How does PharMedQuest Benefit Communities?

Patient Focus

Provider Focus

Quality of Care Focus

• • • •

340B Pharmacy Management Medical Benefit Management Full-Service Specialty Pharmacy Acute & Chronic Disease Patient Management

CLIENTS SERVED • • • •

Federally Qualified Health Centers Health Plans MSOs/IPAs Medical Groups

PUBLICATIONS White Paper Bend the Curve: A New Era for the Management of Specialty Pharmaceuticals (Access Market Intelligence) AMCP/ISPOR Posters USC PhD Fellow’s research posters covering HIV-ART guideline adherence and 340B generic drug utilization were accepted by and presented at AMCP and ISPOR

PHARMEDQUEST: AT A GLANCE

PROGRAMS


340B Management ®

The P340B® Difference: Clients Make Money Upon First Dollar of Revenue

MARKETPLACE FOCUS

DELIVERABLES

2016 BY THE NUMBERS

DIRECT MODEL

Unique Patients Served

PROFIT CENTER

MANAGE BRAND AND GENERIC DRUGS

63,492

FINANCE

OPERATIONS

COMPLIANCE

>892,964 Prescriptions Filled

>99%

Audit Success Rate (HRSA/CMS/PBM/ Joint Commission)


Over the past year, we secured three new Federally Qualified Health Center clients and opened five additional pharmacies. We are proud to share that we have expanded beyond our geographic area in the Los Angeles & Orange Counties to Merced & Stanislaus Counties in Central California. In addition to our physical expansion, our P340B® team has made a number of improvements to optimize our core services and provide advanced reporting & information to our clients. PharMedQuest continues its quest to provide quality, cost-effective pharmaceutical care and documented benefits to our clients. Thank you and we look forward to working with you in 2017.

Duane Saikami, PharmD, MBA Chief Operating Officer

• Outpatient Pharmacy • AIDS Drug Assistance Program (ADAP) • Hepatitis C • Sliding Fee Schedule (SFS) • Programs of All-Inclusive Care for the Elderly (PACE) • County-run Programs

CLIENTS SERVED • Federally Qualified Health Centers • Underserved Communities

2,278

HIV & HEP C PATIENTS SERVED

“We had two pharmacies onsite prior to replacing them with PMQ. The revenue and profit margin after the switch were significantly higher. Making the switch was a great decision.” COO of GVCH

P340B®: 340B MANAGEMENT

PROGRAMS


Medical Benefit Management Breaking New Grounds: The ARC Approach TM

2016 BY THE NUMBERS

13%

Intervention Rate that Improved Care Quality

Drug Savings

Drug-Specific Focus to Disease/Patient Focus

Peer-to-Peer Clinical Review

Single-Drug to Multi-Drug/ Holistic Approach

PMPM to PUPM Focus

8-10%

ARC identifies the clinical & cost management opportunities for Medical & Pharmacy Benefit. TM

“They show where we are in providing high quality. Saves money. Reduces cost. They provide opportunities to improve care.” CMO of OMN

Let our team conduct a free claims analysis.


ARC™ had a busy year -- we optimized the ARC™ infrastructure, clinical evidence-based protocols, and workflow to ensure our services & reporting to our clients are transparent with added documentation. ARC™ continues to provide quality, cost-effective interventions for our patients, providers and payors. In 2017, we will publish research projects sharing our findings, accomplishments and collaborations with our clients.

Anthony Lam, MD, MHS Chief Medical Officer

CASE STUDY : MP00387 MSO

CLIENTS SERVED • Payors • Patients • Providers

• Health Plans • Medicare • Medicaid

COVERED DISEASE STATES • • • • • • •

Hematology/Oncology Rheumatology Endocrinology Infectious Diseases (HIV/HEP C) Neurology OB/GYN Others

8 IPAs

500k Covered Lives

Per-utilizing member-per-month (PUPM) cost decreased at an average of 11% among top-10 diagnoses.

ARCTM: MEDICAL BENEFIT MANAGEMENT

50% of All Specialty Drug Costs Are Billed Through the Medical Benefit


700 E Birch St. #11055, Brea, CA 92822 • P: (714) 364-4008 F: (714) 364-4666 • PharMedQuest.com

© Copyright 2017 NS and Associates, LLC. All right reserved.

Neither this publication nor any part of it may be reproduced without written permission by NS and Associates, LLC.

PMQ Corporate Report 2017